Innovata plc’s Adept Recommended For Marketing Approval By US FDA Panel

March 28, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Innovata PLC said a panel of medical experts that advises the US Food and Drug Administration has recommended its Adept adhesion reduction solution be granted marketing approval for use in obstetric and gynaecologic surgery.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Europe

Food and Drug Administration (FDA)